drugset / Trial / NCT00203177
Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to look at the effectiveness, tolerability and safety of two doses of Rasagiline (0.5 mg and 1mg) in advanced Parkinson's Disease (PD) Patients who have been treated with Levodopa/Carbidopa therapy.
Timeline
- Start
- 2001-10
- Primary completion
- 2006-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rasagiline | Small molecule | 0.5 mg | Oral |
| Subject | Rasagiline | Small molecule | 1 mg | Oral |